Female Infertility Market 2024-2034
                     Female Infertility 
Market Research 
Report 2024-
2034
ABOUT IMARC
International Market Analysis Research and 
Consulting Group is a leading adviser on 
management strategy and market research 
worldwide. We partner with clients in all regions and 
industry verticals to identify their highest-value 
opportunities, address their most critical challenges, 
and transform their businesses.
IMARC’s information products include major market, 
scientific, economic and technological developments 
for business leaders in pharmaceutical, industrial, 
and high technology organizations. Market forecasts 
and industry analysis for biotechnology, advanced 
materials, chemicals, food and beverage, travel and 
tourism, nanotechnology and novel processing 
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable 
insight into the dynamics of companies and markets 
with close cooperation at all levels of the client 
organization. This ensures that our clients achieve2 
unmatchable competitive advantage, build more 
proficient organizations, and secure lasting results.
Report Description and Highlights
Female Infertility Market Report Overview:
• Report Attribute                       Details
• Base Year                                         2023
• Forecast Years                        2024-2034
• Historical Years                        2018-2023
• Market Size in 2023                       US$ 2.0 Billion
• Market Forecast in 2034               US$ 2.7 Billion
• Market Growth (2024-2034)       2.76%
The report offers a comprehensive analysis of the Female Infertility market in the United States, EU5 (including Germany, Spain, Italy, France, 
and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the 
proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance 
of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in 
the report. 3
Report Description and Highlights
This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone 
interested or involved in the Female Infertility market.
Market Overview:
The 7 major female infertility markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group 
expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.76% during 2024-2034.
4
Report Description and Highlights
The market for female infertility is witnessing considerable expansion, propelled by various elements. Female 
infertility is a health condition where a woman cannot get pregnant after one year of frequent, unprotected 
sexual activity or sustain a pregnancy. Lifestyle changes, such as postponing family planning and heightened 
stress, are impacting fertility rates among women. Professional goals and societal changes encouraging 
females to seek advanced education and career growth often delay motherhood, adding to age-related fertility 
problems. The social stigma linked to infertility is gradually fading, replaced by increasing understanding and 
openness towards available treatments. Public campaigns and conversations are making it easier to discuss 
the condition, thereby encouraging more women to seek medical help. Technological progress in Assisted 
Reproductive Technologies (ART), like In Vitro Fertilization (IVF), has enhanced the efficacy of infertility 
solutions. These technologies have better success rates, generating more demand.
Low-cost fertility therapies in emerging economies have made medical tourism an attractive option. Women 
from industrialized nations are increasingly opting for fertility treatments overseas, bolstering the market. 
Some countries are even subsidizing fertility medications as part of healthcare plans, easing the financial5 
strain on couples and enhancing treatment accessibility. 
Report Description and Highlights
Heavy investments in research and development by pharmaceutical firms and medical research organizations 
are leading to innovative medicines and procedures. New techniques such as ovarian tissue preservation and 
uterine transplants offer a more optimistic outlook for infertility treatment. As economic prosperity rises, so 
does disposable income, making it feasible for women to afford infertility services. This financial capability, 
along with the previously outlined factors, is expected to fuel the growth of the female infertility market in the 
near future.
Request a Sample Report: https://www.imarcgroup.com/female-infertility-market/requestsample
6
Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2032
Countries Included:
• United States
• Germany
• France
7
Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Female Infertility market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Female Infertility market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current Female Infertility marketed drugs and 
late-stage pipeline drugs.
8
Report Description and Highlights
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
View Report TOC, Figures and Tables: https://www.imarcgroup.com/female-infertility-market
9
Report Description and Highlights
Competitive Landscape With Key Players:
The competitive landscape of the Female Infertility market has been studied in the report with the detailed 
profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: 
https://www.imarcgroup.com/request?type=report&id=8161&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as 
a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research 
worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, 
address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for 
business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and 
industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and 
tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 1
0
Report Description and Highlights
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: [email protected]
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/
1
1
Key Questions Answered in the Report
1. How has the Female Infertility market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2023 and how are they expected to 
perform till 2034?
3. What was the country-wise size of the Female Infertility market across the seven major markets in 2023 
and what will it look like in 2034?
4. What is the growth rate of the Female Infertility market across the seven major markets and what will be 
the expected growth over the next ten years?
5. What are the key unmet needs in the market?
12
Table of 
Contents
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
14
Table of Contents
4 Female Infertility - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2018-2023) and Forecast (2024-2034)
4.4 Market Overview (2018-2023) and Forecast (2024-2034)
4.5 Competitive Intelligence
5 Female Infertility - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
    
Click here to visit the complete table of content with list of figures and tables: 
https://www.imarcgroup.com/female-infertility-market/toc
15
Partial List Of Our Clients
16
OUR CLIENTS
17
Disclaimer
© 2023 IMARC All Rights Reserved 
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of 
International Market Analysis Research and Consulting (IMARC). No part of this publication may be 
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be 
used in any form or by and means graphic electronic or mechanical, including photocopying, recording, 
taping or by information storage or retrieval, or by any other form, without the express consent of 
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion 
have been based on information and sources believed to be accurate and reliable at the time of 
publishing. International Market Analysis Research and Consulting makes no representation of warranty 
of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability 
whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this 
publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International 
Market Analysis Research and Consulting. All other trademarks used in this publication are registered 
1
trademarks of their respective companies. 8